Literature DB >> 18617753

Clinical and experimental research of corneal lymphangiogenesis after keratoplasty.

Shiqi Ling1, Haotian Lin, Daoman Xiang, Guangqiang Feng, Xuefei Zhang.   

Abstract

The objective of this study is to provide further evidence that corneal lymphangiogenesis occurs after keratoplasty, and to explore the association of corneal hemangiogenesis, corneal inflammation and transplantation history with corneal lymphangiogenesis. Rat corneal lymphangiogenesis was examined by electron microscopy, lymphatic vessel endothelial receptor (LYVE-1) immunohistochemistry, and whole-mount immunofluorescence at 1, 3, 7, 10 and 14 days after corneal transplantation. Blood and lymphatic vessels in human transplanted corneas were identified by LYVE-1 and CD(31) immunohistochemistry, then the association between corneal blood vessel counting, inflammatory index and transplantation history with the lymphatic vessel counting was examined. The results showed that corneal lymphangiogenesis was present in all rat corneas and 26% of human transplanted corneas. Lymphatic vessel counting was significantly associated with blood vessel counting, inflammatory index and transplantation history (all p values <0.0001). We conclude that corneal lymphangiogenesis develops after keratoplasty, and is strongly associated with hemangiogenesis, inflammation and the history of transplantation. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617753     DOI: 10.1159/000144030

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  12 in total

Review 1.  Management of high-risk corneal transplantation.

Authors:  Antonio Di Zazzo; Ahmad Kheirkhah; Tulio B Abud; Sunali Goyal; Reza Dana
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

2.  Relationship between angiogenesis and lymphangiogenesis in recurrent pterygium.

Authors:  Chao-Xiu Qi; Xiao-Dong Zhang; Jin Yuan; Jie-Zhen Yang; Yi Sun; Tao Wang; Hui Ye; Shi-Qi Ling
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

3.  Hemangiogenesis and lymphangiogenesis in corneal pathology.

Authors:  Makambo Tshionyi; Elizabeth Shay; Elisa Lunde; Amy Lin; Kyu-Yeon Han; Sandeep Jain; Jin-Hong Chang; Dimitri T Azar
Journal:  Cornea       Date:  2012-01       Impact factor: 2.651

4.  Topically administered bevacizumab had longer standing anti-angiogenic effect than subconjunctivally injected bevacizumab in rat corneal neovacularization.

Authors:  Jae Kim; Dong Kim; Eun-Soon Kim; Myoung Joon Kim; Hungwon Tchah
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

5.  Attenuation of corneal neovascularization by topical low-molecular-weight heparin-taurocholate 7 without bleeding complication.

Authors:  Jae Yong Kim; Soo Yeon Kim; Mi Hyun Cheon; Eun-Soon Kim; In Seok Song; Myoung Joon Kim; Hungwon Tchah
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

Review 6.  Gene therapy in corneal transplantation.

Authors:  Yureeda Qazi; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

7.  Clinicopathological correlation analysis of (lymph) angiogenesis and corneal graft rejection.

Authors:  Yongxin Zheng; Haotian Lin; Shiqi Ling
Journal:  Mol Vis       Date:  2011-06-25       Impact factor: 2.367

8.  MicroRNA miR-466 inhibits Lymphangiogenesis by targeting prospero-related homeobox 1 in the alkali burn corneal injury model.

Authors:  Minkoo Seo; Jun-Sub Choi; Chang Rae Rho; Choun-Ki Joo; Suk Kyeong Lee
Journal:  J Biomed Sci       Date:  2015-01-02       Impact factor: 8.410

Review 9.  Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

Authors:  Tulio B Abud; Antonio Di Zazzo; Ahmad Kheirkhah; Reza Dana
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar

10.  Lymphatic microvessel density as a predictive marker for the recurrence time of pterygium: a three-year follow-up study.

Authors:  Haotian Lin; Lixia Luo; Shiqi Ling; Wan Chen; Zhaochuan Liu; Xiaojian Zhong; Changrui Wu; Weirong Chen; Yizhi Liu
Journal:  Mol Vis       Date:  2013-01-28       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.